{
    "clinical_study": {
        "@rank": "18204", 
        "arm_group": [
            {
                "arm_group_label": "Placebo control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo control"
            }, 
            {
                "arm_group_label": "Cholecalciferol 1000IU", 
                "arm_group_type": "Active Comparator", 
                "description": "Cholecalciferol 1000IU qd for 8 weeks"
            }, 
            {
                "arm_group_label": "alfacalcidol", 
                "arm_group_type": "Experimental", 
                "description": "alfacalcidol 0.5ug qd for 8 weeks"
            }, 
            {
                "arm_group_label": "Calcitriol", 
                "arm_group_type": "Experimental", 
                "description": "Calcitriol 0.25ug qd for 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effect of inactive and active vitamin D on serum\n      sclerostin and dickkopf1 levels."
        }, 
        "brief_title": "The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoporosis", 
        "condition_browse": {
            "mesh_term": "Osteoporosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male volunteer older than 20 years\n\n        Exclusion Criteria:\n\n          -  Subjects with bone and mineral metabolism disorders\n\n          -  Subjects with kidney or liver diseases\n\n          -  Subjects with uncorrectable hypercalcemia or hypocalcemia\n\n          -  Subjects with chronic gastrointestinal disorders or malabsorption\n\n          -  Subjects taking medication related to bone loss"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "88", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765010", 
            "org_study_id": "SNUH-ENDO-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Calcitriol", 
                "intervention_name": "Calcitriol", 
                "intervention_type": "Drug", 
                "other_name": "Calcio"
            }, 
            {
                "arm_group_label": "alfacalcidol", 
                "intervention_name": "Alfacalcidol", 
                "intervention_type": "Drug", 
                "other_name": "Onealfa"
            }, 
            {
                "arm_group_label": "Cholecalciferol 1000IU", 
                "intervention_name": "Cholecalciferol", 
                "intervention_type": "Drug", 
                "other_name": "DicamaxD"
            }, 
            {
                "arm_group_label": "Placebo control", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcitriol", 
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins", 
                "Hydroxycholecalciferols", 
                "1-hydroxycholecalciferol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vitamin D", 
            "Serum sclerostin", 
            "Serum dickkopf1"
        ], 
        "lastchanged_date": "January 8, 2013", 
        "location": {
            "contact": {
                "email": "csshin@snu.ac.kr", 
                "last_name": "Chan Soo Shin, MD, PhD", 
                "phone": "82220723734"
            }, 
            "contact_backup": {
                "email": "jhkxingfu@gmail.com", 
                "last_name": "Jung Hee Kim, MD", 
                "phone": "8220724839"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Medical School"
            }, 
            "investigator": {
                "last_name": "Chan Soo Shin, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "Comparisons of the Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels", 
        "overall_contact": {
            "email": "csshin@snu.ac.kr", 
            "last_name": "Chan Soo Shin, MD, PhD", 
            "phone": "+82-2-2072-3734"
        }, 
        "overall_contact_backup": {
            "email": "jhkxingfu@gmail.com", 
            "last_name": "Jung Hee Kim, MD", 
            "phone": "+82-2-2072-4839"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Medical School", 
            "last_name": "Chan Soo Shin, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Korea: Ministry for Health, Welfare and Family Affairs"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change of serum sclerostin level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks later"
            }, 
            {
                "measure": "Change of serum Dickkopf1 level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks later"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765010"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change of serum c-telopeptide level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks later"
            }, 
            {
                "measure": "Change of serum bone-specific alkaline phosphatase level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks later"
            }, 
            {
                "measure": "Change of serum calcium level", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks later"
            }, 
            {
                "measure": "Change of serum parathyroid hormone level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks later"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}